John Johnson, Chief Executive Officer at SAVIENT PHARMACEUTICALS INC (SVNT), sold 17,650 shares at $2.30 ($41K) on 2012-01-03, disclosed to the SEC on 2012-01-04.
Scheduled sale ($41k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| XERS | SELL | 2025-12-19 | $978K | — | Filing → |
| AXGN | SELL | 2025-12-10 | $2.8M | — | Filing → |
| XERS | SELL | 2025-08-15 | $787K | — | Filing → |